Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. RIVULET MEDIA INC. (RIVU) Message Board

Well put. For the life of me I do not understand

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 5066
Posted On: 07/01/2013 6:49:56 PM
Avatar
Posted By: patientgal
Re: FD2you #1232

Well put.


For the life of me I do not understand why people who are not willing to at least attempt to understand how the science works, will invest in it. Yeah, I understand the $$$ people see when they think bio & pharma. But seriously, unless you have the money to invest in the established companies who have already mastered the art of total manipulation, why bother if you can't practice some patience?


There is something else I want to point out about the forthcoming news: Regen hired a CRO (contract research organization) to assist with the IND application. If they have contracted any of the responsibility of the trials to Cromos, they too, have to have certain ducks in a row in order for the trials to commence. It doesn't matter that some of the great minds behind Hemxellerate are part of the advisory board. It doesn't matter their success with other trials. They will receive the same scrutiny as any other CRO for any other application.


Further, given that we are talking about intelligent, real time growth factors, should Hemxellerate be granted the go-ahead, changes within the cellular structure will be noted quickly. The patient base for this type of therapy is limited, yes. BUT, similar studies have proved very successful. This science is 4 decades plus in the making and the potential cells of interest have been narrowed. This is not a shot-in-the-dark they are taking. This is the science that many a men & women damn near drove themselves mad creating.


I am honored to have added considerably to the coffers by stealing from my kids' piggy bank.  :-D


BMSN



(0)
(0)




RIVULET MEDIA INC. (RIVU) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us